Persons
Webseiten-Inhalte
New study opens up promising therapeutic prospects for rare skin cancer
..., Dagmar Stoiber, Gang Yin, David Horst, Anja Fischer, Reiner Siebert, Jan P Nicolay, Menghong Yin, Martin Janz, Falko Fend, Jürgen C Becker, Christian M Schürch, Lukas Kenner, Chalid Assaf, Olaf Merkel and Stephan Mathas Br J Dermatol 2025; 00:1-13 https://doi.org/10.1093/bjd/ljaf001 Charité spotlight...
https://www.meduniwien.ac.at/web/en/ueber-uns/news/2025/news-in-march-2025/new-study-opens-up-promising-therapeutic-prospects-for-rare-skin-cancer/medicine-science/
New study opens up promising therapeutic prospects for rare skin cancer
..., Dagmar Stoiber, Gang Yin, David Horst, Anja Fischer, Reiner Siebert, Jan P Nicolay, Menghong Yin, Martin Janz, Falko Fend, Jürgen C Becker, Christian M Schürch, Lukas Kenner, Chalid Assaf, Olaf Merkel and Stephan Mathas Br J Dermatol 2025; 00:1-13 https://doi.org/10.1093/bjd/ljaf001 Charité spotlight...
https://www.meduniwien.ac.at/web/en/ueber-uns/news/2025/news-in-march-2025/new-study-opens-up-promising-therapeutic-prospects-for-rare-skin-cancer/
Detailsite | MedUni Vienna
... Geyeregger, PhD, Michaela Schlederer, Lukas Kenner, MD, and Thomas M. Stulnig, MD. Neutralization of osteopontin inhibits obesity-induced inflammation and insulin resistance. Diabetes. 2010 Share WhatsappFacebookTwitterLinkedInXingMail All News...
https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/key-molecule-identified-in-the-origin-of-insulin-resistance/
Forschungsteam identifiziert neues Therapieziel für L-CTCL-Hautkrebs
... Heitzer, Patrick T Gunning, Lukas Kenner, Richard Moriggl, Peter Wolf https://doi.org/10.15252/emmm.202115200 https://www.embopress.org/doi/full/10.15252/emmm.202115200 Share Whatsapp Facebook Twitter LinkedIn Xing Mail Alle News...
https://www.meduniwien.ac.at/web/ueber-uns/news/2022/news-im-dezember-2022/forschungsteam-identifiziert-neues-therapieziel-fuer-l-ctcl-hautkrebs/medizin-wissenschaft/
Forschungsteam identifiziert neues Therapieziel für L-CTCL-Hautkrebs
... Heitzer, Patrick T Gunning, Lukas Kenner, Richard Moriggl, Peter Wolf https://doi.org/10.15252/emmm.202115200 https://www.embopress.org/doi/full/10.15252/emmm.202115200 Share Whatsapp Facebook Twitter LinkedIn Xing Mail Alle News...
https://www.meduniwien.ac.at/web/ueber-uns/news/2022/news-im-dezember-2022/forschungsteam-identifiziert-neues-therapieziel-fuer-l-ctcl-hautkrebs/
Austrian research team identifies new therapeutic target for leukemic cutaneous T-cell lymphoma
..., Olasunkanmi O Olaoye, Martin L Metzelder, Anna Orlova, Walter Berger, Marion Wobser, Jan P Nicolay, Fiona André, Van Anh Nguyen, Heidi A Neubauer, Roman Fleck, Olaf Merkel, Marco Herling, Ellen Heitzer, Patrick T Gunning, Lukas Kenner, Richard Moriggl, Peter Wolf https://doi.org/10.15252/emmm.202115200 https...
https://www.meduniwien.ac.at/web/en/ueber-uns/news/2022/news-im-dezember-2022/forschungsteam-identifiziert-neues-therapieziel-fuer-l-ctcl-hautkrebs/
Austrian research team identifies new therapeutic target for leukemic cutaneous T-cell lymphoma
..., Olasunkanmi O Olaoye, Martin L Metzelder, Anna Orlova, Walter Berger, Marion Wobser, Jan P Nicolay, Fiona André, Van Anh Nguyen, Heidi A Neubauer, Roman Fleck, Olaf Merkel, Marco Herling, Ellen Heitzer, Patrick T Gunning, Lukas Kenner, Richard Moriggl, Peter Wolf https://doi.org/10.15252/emmm.202115200 https...
https://www.meduniwien.ac.at/web/en/ueber-uns/news/2022/news-im-dezember-2022/forschungsteam-identifiziert-neues-therapieziel-fuer-l-ctcl-hautkrebs/medicine-science/
Detailsite | MedUni Vienna
... brain metastases in association with ALK-positive lung cancer in Austria every year. Last year, the MedUni Vienna scored a high-profile success for the group led by Lukas Kenner in the treatment of aggressive lymphoma-type ALCL involving a treatment targeted at an ALK gene (NPM-ALK) with a specific...
https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/new-treatment-option-for-brain-metastases-associated-with-lung-cancer/
Supervisors | MedUni Vienna
... topics and further information Eniko Kallay Center for Pathophysiology, Infectiology and Immunology +43 1 40400-51230 enikoe.kallay@meduniwien.ac.at Research topics and further information on the MUW researcher profiles website Lukas Kenner Department of Pathology +43 1 40400-36590 lukas.kenner@meduniwien.ac.at Research topics and further information Hans Kiener Department of Internal Medicine III hans.kiener@meduniwien.ac.at Research topics and further information on the MUW researcher profiles website Martin Knöfler Department of Obstetrics and Gynecology +43...
https://www.meduniwien.ac.at/web/en/studies-further-education/phd-doctoral-programmes/phd-programme-un094/phd-thematic-programs/molecular-signal-transduction/about-the-program/supervisor/
Supervisor:innen | MedUni Wien
... topics and further information Eniko Kallay Center for Pathophysiology, Infectiology and Immunology +43 1 40400-51230 enikoe.kallay@meduniwien.ac.at Research topics and further information on the MUW researcher profiles website Lukas Kenner Department of Pathology +43 1 40400-36590 lukas.kenner@meduniwien.ac.at Research topics and further information Hans Kiener Department of Internal Medicine III hans.kiener@meduniwien.ac.at Research topics and further information on the MUW researcher profiles website Martin Knöfler Department of Obstetrics and Gynecology +43...
https://www.meduniwien.ac.at/web/studium-weiterbildung/phd-und-doktoratsstudien/phd-studium/phd-thematische-programme/molecular-signal-transduction/ueber-das-programm/supervisorinnen/